SMADS AS INTRACELLULAR MEDIATORS OF AIRWAY INFLAMMATION
暂无分享,去创建一个
I. Adcock | D. Groneberg | G. Hansen | H. Witt | J. Springer
[1] H. Daniel,et al. Renal Assimilation of Short Chain Peptides: Visualization of Tubular Peptide Uptake , 2002, Pharmaceutical Research.
[2] D. Groneberg,et al. Expression of Immediate Early Genes in Sensory Ganglia , 2001, Neurochemical Research.
[3] R. Chambers,et al. Angiotensin II and the fibroproliferative response to acute lung injury. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[4] B. Beghé,et al. Airway inflammation in childhood asthma. , 2003, American journal of respiratory and critical care medicine.
[5] M. Kolb,et al. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. , 2003, American journal of respiratory and critical care medicine.
[6] H. Schnaper,et al. Smad3 and PKCδ mediate TGF-β1-induced collagen I expression in human mesangial cells , 2003 .
[7] D. Warburton,et al. Burkholderia cepacia–Induced IL-8 Gene Expression in an Alveolar Epithelial Cell Line: Signaling Through CD14 and Mitogen-Activated Protein Kinase , 2003, Pediatric Research.
[8] N. Frossard,et al. Transforming growth factor-β and its role in asthma , 2003 .
[9] S. Phan,et al. TGF‐β1‐induced Smad 3 binding to the Smad 7 gene: Knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF‐β1 secretion: Bleomycin acts through TGF‐β1 , 2003 .
[10] D. Groneberg,et al. Calcitonin gene-related peptide as inflammatory mediator. , 2003, Pulmonary pharmacology & therapeutics.
[11] T. Ishizuka,et al. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. , 2003, American journal of respiratory cell and molecular biology.
[12] R. Balling,et al. Targeted Disruption of the Peptide Transporter Pept2 Gene in Mice Defines Its Physiological Role in the Kidney , 2003, Molecular and Cellular Biology.
[13] B. Van Houten,et al. Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[14] U. Wahn,et al. Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.
[15] J. Bonventre,et al. Stretch-induced IL-8 depends on c-Jun NH2-terminal and nuclear factor-kappaB-inducing kinases. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[16] D. Groneberg,et al. Toxic Rhinitis-Induced Changes of Human Nasal Mucosa Innervation , 2003, Toxicologic pathology.
[17] D A Groneberg,et al. Fundamentals of pulmonary drug delivery. , 2003, Respiratory medicine.
[18] D. Tindall,et al. TGF-ß/Smad Signaling in Prostate Cancer , 2003 .
[19] A. Grinberg,et al. Both Max and TFE3 Cooperate with Smad Proteins to Bind the Plasminogen Activator Inhibitor-1 Promoter, but They Have Opposite Effects on Transcriptional Activity* 210 , 2003, The Journal of Biological Chemistry.
[20] D. Taatjes,et al. Persistent localization of activated extracellular signal-regulated kinases (ERK1/2) is epithelial cell-specific in an inhalation model of asbestosis. , 2003, The American journal of pathology.
[21] Axel Fischer,et al. Distribution of Respiratory Mucin Proteins in Human Nasal Mucosa , 2003, The Laryngoscope.
[22] P. Thistlethwaite,et al. Signaling molecules in nonfamilial pulmonary hypertension. , 2003, The New England journal of medicine.
[23] P. Galle,et al. TGF-β Regulates Airway Responses Via T Cells 1 , 2003, The Journal of Immunology.
[24] M. Humbert,et al. Difficult asthma , 2003, Allergy.
[25] S. French,et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. , 2003, Journal of immunology.
[26] R. Townley,et al. Airway hyperresponsiveness , 2003, Clinical reviews in allergy & immunology.
[27] D. Groneberg,et al. Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. , 2003, American journal of respiratory cell and molecular biology.
[28] P. Howarth,et al. Pharmacotherapy and airway remodelling in asthma? , 2003, Thorax.
[29] K. Chung,et al. Role of Nitric Oxide in Chronic Allergen-Induced Airway Cell Proliferation and Inflammation , 2003, Journal of Pharmacology and Experimental Therapeutics.
[30] S. Phan,et al. TGF-beta1-induced Smad 3 binding to the Smad 7 gene: knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF-beta1 secretion: bleomycin acts through TGF-beta1. , 2003, Journal of cellular biochemistry.
[31] P. Galle,et al. TGF-beta regulates airway responses via T cells. , 2003, Journal of immunology.
[32] D. Tindall,et al. TGF-betal/Smad signaling in prostate cancer. , 2003, Current drug targets.
[33] D. Groneberg,et al. Re-uptake mechanisms of peptide fragments after DPP IV-mediated proteolysis in the peripheral nervous system. , 2003, Advances in experimental medicine and biology.
[34] H. Schnaper,et al. Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. , 2003, American journal of physiology. Renal physiology.
[35] N. Frossard,et al. Transforming growth factor-beta and its role in asthma. , 2003, Pulmonary pharmacology & therapeutics.
[36] T. Fukuda,et al. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. , 2002, The Journal of allergy and clinical immunology.
[37] M. Matzuk,et al. Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily , 2002 .
[38] R. Derynck,et al. Transforming Growth Factor-β Inhibits Pulmonary Surfactant Protein B Gene Transcription through SMAD3 Interactions with NKX2.1 and HNF-3 Transcription Factors* , 2002, The Journal of Biological Chemistry.
[39] D. Groneberg,et al. Innervation of Human Nasal Mucosa in Environmentally Triggered Hyperreflectoric Rhinitis , 2002, Journal of occupational and environmental medicine.
[40] I. Adcock,et al. Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. , 2002, European journal of pharmacology.
[41] F. Lallemand,et al. c-Jun Associates with the Oncoprotein Ski and Suppresses Smad2 Transcriptional Activity* , 2002, The Journal of Biological Chemistry.
[42] C. Heldin,et al. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. , 2002, American journal of respiratory cell and molecular biology.
[43] A. Yoshimura,et al. Regulation of cytokine signaling and inflammation. , 2002, Cytokine & growth factor reviews.
[44] D. Groneberg,et al. Distribution of salivary aquaporin-5 in Sjögren's syndrome , 2002, The Lancet.
[45] D. Groneberg,et al. Mediators of asthma: nitric oxide. , 2002, Pulmonary pharmacology & therapeutics.
[46] H. Daniel,et al. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. , 2002, American journal of physiology. Endocrinology and metabolism.
[47] R. Trembath,et al. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor , 2002, Circulation.
[48] A. Nicholson,et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma , 2002, Histopathology.
[49] W. Seeger,et al. Genomic organization and regulation of a human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia. , 2002, Biochemical and biophysical research communications.
[50] D. Groneberg,et al. Leptin receptor expression in nodose ganglion cells projecting to the rat gastric fundus , 2002, Neuroscience Letters.
[51] J. Kere,et al. Down-regulated in adenoma mediates apical Cl-/HCO3- exchange in rabbit, rat, and human duodenum. , 2002, Gastroenterology.
[52] G. Chiappara,et al. Cellular network in airways inflammation and remodelling. , 2002, Paediatric respiratory reviews.
[53] J. Rosenbloom,et al. Transforming Growth Factor- β Stabilizes Elastin mRNA by a Pathway Requiring Active Smads, Protein Kinase C- δ , and p38 , 2002 .
[54] D. Groneberg,et al. Simultaneous detection of receptor mRNA and ligand protein in human skin tissues , 2002, Journal of cutaneous pathology.
[55] A. Nicholson,et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. , 2002, Respiratory medicine.
[56] K. Chung,et al. Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung , 2002, Thorax.
[57] S. Lau,et al. Interactions between genes and environmental factors in asthma and atopy: new developments , 2001, Respiratory research.
[58] E. D. De Robertis,et al. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. , 2002, Nature cell biology.
[59] N. Frossard,et al. Nerve growth factor and asthma. , 2002, Pulmonary pharmacology & therapeutics.
[60] D. Huylebroeck,et al. Complex Smad-dependent transcriptional responses in vertebrate development and human disease. , 2002, Critical Reviews in Eukaryotic Gene Expression.
[61] K. Miyazono. Regulation of transforming growth factor-beta signaling and vascular diseases. , 2002, Cornea.
[62] R. Flavell,et al. Transforming growth factor-beta in T-cell biology. , 2002, Nature reviews. Immunology.
[63] H. Ihn. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma. , 2002, Archivum immunologiae et therapiae experimentalis.
[64] M. Matzuk,et al. Genetic analysis of the mammalian transforming growth factor-beta superfamily. , 2002, Endocrine reviews.
[65] P. Sterk. Airway hyperresponsiveness: using bronchial challenge tests in research and management of asthma. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[66] J. Wrana,et al. TGF-beta and the Smad signal transduction pathway. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[67] J. Rosenbloom,et al. Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. , 2002, American journal of respiratory cell and molecular biology.
[68] D. Groneberg,et al. Abundant Expression of c-Jun in Guinea Pig Sympathetic Ganglia Under Basal Conditions and Allergen Challenge , 2002, Lung.
[69] P. Henricks,et al. Reactive oxygen species as mediators in asthma. , 2001, Pulmonary pharmacology & therapeutics.
[70] M. Lu,et al. The bone morphogenic protein antagonist gremlin regulates proximal‐distal patterning of the lung , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.
[71] S. Sebti,et al. Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. , 2001, Archives of biochemistry and biophysics.
[72] I. Adcock,et al. TGFβ1 allele association with asthma severity , 2001, Human Genetics.
[73] D. Groneberg,et al. Vasoactive intestinal polypeptide as mediator of asthma. , 2001, Pulmonary pharmacology & therapeutics.
[74] P. Barnes,et al. Histamine and serotonin. , 2001, Pulmonary pharmacology & therapeutics.
[75] D. Groneberg,et al. Endogenous opioids as mediators of asthma. , 2001, Pulmonary pharmacology & therapeutics.
[76] F. Lallemand,et al. Evidence for a Role of the JNK Cascade in Smad7-mediated Apoptosis* , 2001, The Journal of Biological Chemistry.
[77] D. Groneberg,et al. Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. , 2001, The Journal of investigative dermatology.
[78] D. Groneberg,et al. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[79] J. Kips,et al. Cytokines in asthma , 2001, European Respiratory Journal.
[80] C. Heldin,et al. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. , 2001, American journal of respiratory cell and molecular biology.
[81] M. Caestecker,et al. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension , 2001, Respiratory research.
[82] J. Moffatt,et al. Protease-activated receptor-2 (PAR2) in the airways. , 2001, Pulmonary pharmacology & therapeutics.
[83] H. Daniel,et al. Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia , 2001, Neuroscience Letters.
[84] D. Groneberg,et al. Expression and Distribution of Vasoactive Intestinal Polypeptide Receptor VPAC2 mRNA in Human Airways , 2001, Laboratory Investigation.
[85] D. Warburton,et al. Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[86] P. Barnes,et al. Th2 cytokines and asthma: an introduction , 2001, Respiratory research.
[87] Serhiy Souchelnytskyi,et al. Regulation of Smad signaling by protein kinase C , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[88] A. Nakao. Is TGF-β1 the key to suppression of human asthma? , 2001 .
[89] D. Groneberg,et al. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. , 2001, The American journal of pathology.
[90] A. Nakao. Is TGF-beta1 the key to suppression of human asthma? , 2001, Trends in immunology.
[91] G. Rovati,et al. Leukotrienes as mediators of asthma. , 2001, Pulmonary pharmacology & therapeutics.
[92] I. Adcock,et al. TGFbeta1 allele association with asthma severity. , 2001, Human genetics.
[93] I. Adcock,et al. Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effect of inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.
[94] M. Gimbrone,et al. Inhibition of E-Selectin Gene Expression by Transforming Growth Factor β in Endothelial Cells Involves Coactivator Integration of Smad and Nuclear Factor κB–Mediated Signals , 2000, The Journal of experimental medicine.
[95] D. Brigstock,et al. Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.
[96] C. Chatziantoniou,et al. Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway , 2000, Hypertension.
[97] M. Hatano,et al. Blockade of Transforming Growth Factor β/Smad Signaling in T Cells by Overexpression of Smad7 Enhances Antigen-Induced Airway Inflammation and Airway Reactivity , 2000, The Journal of experimental medicine.
[98] P. Howarth,et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] Hiroshi Shibuya,et al. BMP2-induced Apoptosis Is Mediated by Activation of the TAK1-p38 Kinase Pathway That Is Negatively Regulated by Smad6* , 2000, The Journal of Biological Chemistry.
[100] S. Hirst,et al. Airway smooth muscle as a target in asthma. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[101] S. Holgate,et al. Epithelial damage and response. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[102] K. Yanagisawa,et al. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers , 2000, Oncogene.
[103] Phillip D. Zamore,et al. RNA Interference , 2000, Science.
[104] T. Nakanishi,et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. , 2000, The Journal of rheumatology.
[105] G. Berry,et al. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. , 2000, The Journal of clinical investigation.
[106] N. Khalil. TGF-β: from latent to active , 1999 .
[107] C. Heldin,et al. Specificity, diversity, and regulation in TGF‐β superfamily signaling , 1999 .
[108] Jeffrey B. Kopp,et al. TGF- and fibrosis , 1999 .
[109] S. Silbiger,et al. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. , 1999, American journal of physiology. Renal physiology.
[110] M. Spiteri,et al. Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. , 1999, American journal of respiratory cell and molecular biology.
[111] C. Plopper,et al. The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. , 1999, American journal of respiratory cell and molecular biology.
[112] S. Hubchak,et al. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. , 1999, Kidney international.
[113] F. Marumo,et al. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. , 1999, Kidney international.
[114] F. Marumo,et al. TGF-βbgr-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells , 1999 .
[115] M. Takigawa,et al. Role and interaction of connective tissue growth factor with transforming growth factor‐β in persistent fibrosis: A mouse fibrosis model , 1999, Journal of cellular physiology.
[116] B. Hogan,et al. Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development. , 1999, Development.
[117] S. Mai,et al. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. , 1999, The American journal of pathology.
[118] F. Beier,et al. Serum induction of the collagen X promoter requires the Raf/MEK/ERK and p38 pathways. , 1999, Biochemical and biophysical research communications.
[119] K. Shirato,et al. Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. , 1999, American journal of respiratory cell and molecular biology.
[120] Shokei Kim,et al. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. , 1999, Hypertension.
[121] R. Derynck,et al. Regulation of Smad signalling by protein associations and signalling crosstalk. , 1999, Trends in cell biology.
[122] K. Miyazono. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. , 1999, Bone.
[123] F. Folli,et al. Insulin and insulin‐like growth factor‐1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways , 1999, Hepatology.
[124] Yoram Vodovotz,et al. Regulation of transforming growth factor b1 by nitric oxide , 1999 .
[125] Y. Vodovotz,et al. Regulation of transforming growth factor beta1 by nitric oxide. , 1999, Cancer research.
[126] Xing Shen,et al. Smads bind directly to the Jun family of AP-1 transcription factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[127] E. Nishida,et al. Identification of Two Smad4 Proteins in Xenopus , 1999, The Journal of Biological Chemistry.
[128] J. Massagué,et al. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.
[129] D. Brigstock. The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .
[130] S. Tashiro,et al. ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.
[131] J. D. Brown,et al. MEKK-1, a Component of the Stress (Stress-activated Protein Kinase/c-Jun N-terminal Kinase) Pathway, Can Selectively Activate Smad2-mediated Transcriptional Activation in Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[132] P. Howe,et al. TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.
[133] K. Miyazono,et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. , 1999, Science.
[134] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.
[135] J. Kopp,et al. TGF-beta and fibrosis. , 1999, Microbes and infection.
[136] F. Marumo,et al. TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. , 1999, Kidney international.
[137] L. Gold. The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.
[138] R. Frey,et al. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. , 1999, Oncogene.
[139] N. Khalil. TGF-beta: from latent to active. , 1999, Microbes and infection.
[140] C. Heldin,et al. Specificity, diversity, and regulation in TGF-beta superfamily signaling. , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[141] R. Derynck,et al. Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.
[142] K. Chung,et al. Inflammatory mediators of asthma: an update. , 1998, Pharmacological reviews.
[143] V. Lagente,et al. Tachykinins and airway function. , 1998, Pulmonary pharmacology & therapeutics.
[144] H. Lodish,et al. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.
[145] Yigong Shi,et al. Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.
[146] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[147] K. Kinzler,et al. Characterization of human FAST-1, a TGFβ and activin signal transducer , 1998 .
[148] R. Hynes,et al. Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.
[149] A. Moustakas,et al. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[150] A. Roberts,et al. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. , 1998, Genes & development.
[151] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[152] Hoshino,et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[153] A. Roberts. Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.
[154] K. Kinzler,et al. Characterization of human FAST-1, a TGF beta and activin signal transducer. , 1998, Molecular cell.
[155] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[156] R. Derynck,et al. Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.
[157] A. Roberts. Molecular and cell biology of TGF-beta. , 1998, Mineral and electrolyte metabolism.
[158] W. Border,et al. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. , 1998, Hypertension.
[159] Xiao-Fan Wang,et al. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein , 1997, Molecular and cellular biology.
[160] J. Massagué,et al. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. , 1997, Genes & development.
[161] K. Shirato,et al. TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. , 1997, Journal of immunology.
[162] R. Derynck,et al. TGF-beta receptor signaling. , 1997, Biochimica et biophysica acta.
[163] M. C. Hu,et al. Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction* , 1997, The Journal of Biological Chemistry.
[164] P. Howarth,et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. , 1997, American journal of respiratory and critical care medicine.
[165] Yigong Shi,et al. A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.
[166] J. Massagué,et al. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.
[167] R. Derynck,et al. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 , 1997, Molecular and cellular biology.
[168] M. Reiss,et al. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[169] T. Musci,et al. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.
[170] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[171] K. Miyazono,et al. Bone morphogenetic protein receptors. , 1996, Bone.
[172] K. Miyazono,et al. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. , 1997, Nature.
[173] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[174] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[175] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[176] K. Skorecki,et al. Extracellular Signal-regulated Kinase and the Small GTP-binding Protein, Rac, Contribute to the Effects of Transforming Growth Factor-β1 on Gene Expression* , 1996, The Journal of Biological Chemistry.
[177] Y. Yatabe,et al. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. , 1996, Cancer research.
[178] K. Irie,et al. A Novel Kinase Cascade Mediated by Mitogen-activated Protein Kinase Kinase 6 and MKK3* , 1996, The Journal of Biological Chemistry.
[179] Kathleen R. Cho,et al. DPC4 gene in various tumor types. , 1996, Cancer research.
[180] R. Lotan,et al. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. , 1996, Cancer research.
[181] K. Irie,et al. TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction , 1996, Science.
[182] D. Beno,et al. Raf and Mitogen-activated Protein Kinase Regulate Stellate Cell Collagen Gene Expression (*) , 1996, The Journal of Biological Chemistry.
[183] Y. Kaneda,et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.
[184] Y. Ouchi,et al. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. , 1996, The American journal of pathology.
[185] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[186] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. , 1996, Nature.
[187] K. Irie,et al. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. , 1996, Science.
[188] T. Mitsudomi,et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. , 1996, Cancer research.
[189] K. Irie,et al. Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction , 1995, Science.
[190] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[191] D. Rifkin,et al. Characterization of latent TGF-beta activation by murine peritoneal macrophages. , 1995, Journal of immunology.
[192] K. M. Mulder,et al. Transforming Growth Factor β Activation of p44mapk in Proliferating Cultures of Epithelial Cells (*) , 1995, The Journal of Biological Chemistry.
[193] L. Mahadevan,et al. Parallel signal processing among mammalian MAPKs. , 1995, Trends in biochemical sciences.
[194] S. Schultz-Cherry,et al. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. , 1994, The Journal of biological chemistry.
[195] J. Massagué,et al. TGF-beta receptors and actions. , 1994, Biochimica et biophysica acta.
[196] D. Kingsley,et al. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.
[197] S. Schultz-Cherry,et al. Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism [published erratum appears in J Cell Biol 1993 Sep;122(5):following 1143] , 1993, Journal of Cell Biology.
[198] J. Massagué,et al. Betaglycan presents ligand to the TGFβ signaling receptor , 1993, Cell.
[199] Gary R. Grotendorst,et al. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.
[200] M. Sporn,et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[201] J. Massagué,et al. Betaglycan presents ligand to the TGF beta signaling receptor. , 1993, Cell.
[202] Jeffrey L. Wrana,et al. TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.
[203] J. Massagué,et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.
[204] S. Wahl. Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. , 1992, Journal of clinical immunology.
[205] J. Massagué,et al. TGF beta signals through a heteromeric protein kinase receptor complex. , 1992, Cell.
[206] Gary R. Grotendorst,et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.
[207] H. D. Liggitt,et al. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[208] S. Wahl,et al. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. , 1991, The Journal of clinical investigation.
[209] M. Sporn,et al. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. , 1990, The Journal of clinical investigation.
[210] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[211] M. Letarte,et al. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. , 1990, The Journal of biological chemistry.
[212] E. Ruoslahti,et al. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. , 1990, Nature.
[213] P. G. Holt,et al. Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[214] J. Massagué,et al. The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. , 1988, The Journal of biological chemistry.
[215] A. Roberts,et al. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. , 1988, Journal of immunology.
[216] H. Shepard,et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta , 1987, The Journal of experimental medicine.
[217] M. Sporn,et al. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. , 1986, Journal of immunology.
[218] M. Sporn,et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth , 1986, The Journal of experimental medicine.